Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Rivas

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Revista De Neurologia|July 31, 2013
[Metabolic myopathies]Óscar Papazian, Rafael Rivas-Chacón
Health Physics|August 12, 2010
Preconceptional paternal exposure to depleted uranium: transmission of genetic damage to offspringAlexandra C Miller, Michael Stewart, Rafael Rivas
Biochimie|March 28, 2009
DNA methylation during depleted uranium-induced leukemiaAlexandra C Miller, Michael Stewart, Rafael Rivas
Cells|August 9, 2024
The Potential of Metabolomics to Find Proper Biomarkers for Addressing the Neuroprotective Efficacy of Drugs Aimed at Delaying Parkinson's and Alzheimer's Disease ProgressionRafael Franco, Claudia Garrigós, Jaume Lillo, et al.
Antioxidants (Basel, Switzerland)|October 28, 2023
The NADPH Link between the Renin Angiotensin System and the Antioxidant Mechanisms in Dopaminergic NeuronsRafael Franco, Joan Serrano-Marín, Gemma Navarro, et al.
Cells|November 27, 2021
Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and ImmunotherapyRafael Franco, Rafael Rivas-Santisteban, Gemma Navarro, et al.
Frontiers in Pharmacology|February 15, 2021
The Old and New Visions of Biased Agonism Through the Prism of Adenosine Receptor Signaling and Receptor/Receptor and Receptor/Protein InteractionsRafael Franco, Rafael Rivas-Santisteban, Irene Reyes-Resina, et al.
Radiation and Environmental Biophysics|September 6, 2011
Radioprotection by the histone deacetylase inhibitor phenylbutyrateAlexandra C Miller, Stuart Cohen, Michael Stewart, et al.
Neuropharmacology|November 29, 2024
GPR88 impairs the signaling of kappa opioid receptors in a heterologous system and in primary striatal neuronsRafael Rivas-Santisteban, Jaume Lillo, Claudia Garrigós, et al.
Advances in Experimental Medicine and Biology|December 17, 2020
Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer's, Parkinson's, and Huntington's DiseasesCatalina Pérez-Olives, Rafael Rivas-Santisteban, Jaume Lillo, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Revista De Neurologia|July 31, 2013
[Metabolic myopathies]Óscar Papazian, Rafael Rivas-Chacón
Health Physics|August 12, 2010
Preconceptional paternal exposure to depleted uranium: transmission of genetic damage to offspringAlexandra C Miller, Michael Stewart, Rafael Rivas
Biochimie|March 28, 2009
DNA methylation during depleted uranium-induced leukemiaAlexandra C Miller, Michael Stewart, Rafael Rivas
Cells|August 9, 2024
The Potential of Metabolomics to Find Proper Biomarkers for Addressing the Neuroprotective Efficacy of Drugs Aimed at Delaying Parkinson's and Alzheimer's Disease ProgressionRafael Franco, Claudia Garrigós, Jaume Lillo, et al.
Antioxidants (Basel, Switzerland)|October 28, 2023
The NADPH Link between the Renin Angiotensin System and the Antioxidant Mechanisms in Dopaminergic NeuronsRafael Franco, Joan Serrano-Marín, Gemma Navarro, et al.
Cells|November 27, 2021
Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and ImmunotherapyRafael Franco, Rafael Rivas-Santisteban, Gemma Navarro, et al.
Frontiers in Pharmacology|February 15, 2021
The Old and New Visions of Biased Agonism Through the Prism of Adenosine Receptor Signaling and Receptor/Receptor and Receptor/Protein InteractionsRafael Franco, Rafael Rivas-Santisteban, Irene Reyes-Resina, et al.
Radiation and Environmental Biophysics|September 6, 2011
Radioprotection by the histone deacetylase inhibitor phenylbutyrateAlexandra C Miller, Stuart Cohen, Michael Stewart, et al.
Neuropharmacology|November 29, 2024
GPR88 impairs the signaling of kappa opioid receptors in a heterologous system and in primary striatal neuronsRafael Rivas-Santisteban, Jaume Lillo, Claudia Garrigós, et al.
Advances in Experimental Medicine and Biology|December 17, 2020
Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer's, Parkinson's, and Huntington's DiseasesCatalina Pérez-Olives, Rafael Rivas-Santisteban, Jaume Lillo, et al.
Pageof 6